Healthline: Why self-esteem matters
November 10, 2022
The University of Cincinnati's Shana Feibel spoke with Healthline about the importance of self-esteem.
November 10, 2022
The University of Cincinnati's Shana Feibel spoke with Healthline about the importance of self-esteem.
November 9, 2022
WCPO featured the University of Cincinnati's Rifat Wahab in an article about racial disparities in breast cancer diagnoses and work being done to address the issue.
November 8, 2022
The University of Cincinnati's Stacie Demel, DO, PhD, joined the Simply Medicine podcast to discuss TNK, a new treatment for acute ischemic stroke now available to patients across Greater Cincinnati.
November 7, 2022
MSN India highlighted recent research led by the University of Cincinnati's Trisha Wise-Draper about how immunotherapy and immunosuppression affects COVID-19 severity.
November 3, 2022
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, is co-corresponding author of new research in JAMA Oncology that provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity.
November 3, 2022
The University of Cincinnati's Rhonna Shatz was featured in a U.S. News and World Report article on signs that a patient with dementia may need a higher level of care.
November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.
October 26, 2022
The University of Cincinnati's Kelly Dobos was featured in a Washington Post article about the recent recall of more than a dozen dry shampoos due to the possibility they contain “elevated levels” of benzene.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
October 24, 2022
University of Cincinnati researchers presented results from the first-in-human trial of FLASH radiotherapy at the ASTRO 2022 annual meeting, with data suggesting FLASH may hold promise as a potential treatment for tough-to-kill tumors.